Boston Biomedical Research Institute

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boston Biomedical Research Institute.The latest application filed is for "immunological control of beta-amyloid levels in vivo".

Company Profile

0.18.13

Boston Biomedical Research Institute - Watertown MA US
Boston Biomedical Research Institute -
Boston Biomedical Research Institute - 64 Grove Street Watertown MA
Boston Biomedical Research Institute - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunological Control Of Beta-amyloid Levels In Vivo App 20160039915 - Raso; Victor	2016-02-11
Immunological Control Of Beta-amyloid Levels In Vivo App 20140086937 - Raso; Victor	2014-03-27
Leptin peptide antagonists Grant 8,058,228 - Gonzalez , et al. November 15, 2	2011-11-15
Inhibition of FGF signaling Grant 7,968,527 - Emerson, Jr. , et al. June 28, 2	2011-06-28
Immunological control of .beta.-amyloid levels in vivo Grant 7,906,626 - Raso March 15, 2	2011-03-15
Compositions and Methods for Binding or Inactivating Ghrelin App 20100254994 - Raso; Victor	2010-10-07
Immunological modulation of insulin-like growth factor 1 for cancer prevention/treatment and prolonging longevity Grant 7,749,966 - Raso July 6, 2	2010-07-06
Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death Grant 7,709,216 - Erhardt , et al. May 4, 2	2010-05-04
Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2 Grant 7,612,043 - Gonzalez , et al. November 3, 2	2009-11-03
Methods and compositions for specific inhibition of protein splicing by small molecules Grant 7,553,832 - Paulus June 30, 2	2009-06-30
Leptin peptide antagonists App 20090029919 - Gonzalez; Ruben Rene ; et al.	2009-01-29
Methods and compositions relating to anthrax pathogenesis Grant 7,462,472 - Tang , et al. December 9, 2	2008-12-09
Immunological control of .beta.-amyloid levels in vivo Grant 7,413,884 - Raso August 19, 2	2008-08-19
Leptin peptide antagonists Grant 7,407,929 - Gonzalez , et al. August 5, 2	2008-08-05
Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death App 20080009030 - Erhardt; Peter ; et al.	2008-01-10
Immunological control of beta-amyloid levels in vivo App 20060228371 - Raso; Victor	2006-10-12
Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death App 20050250724 - Erhardt, Peter ; et al.	2005-11-10
Immunological control of beta-amyloid levels in vivo App 20050147613 - Raso, Victor	2005-07-07
Immunological control of .beta.-amyloid levels in vivo Grant 6,872,554 - Raso March 29, 2	2005-03-29
Methods for delaying or inducing labor App 20050014676 - Li, Yunping ; et al.	2005-01-20
Immunological control of beta-amyloid levels in vivo App 20030235897 - Raso, Victor	2003-12-25
Immunological control of .beta.-amyloid levels in vivo Grant 6,582,945 - Raso June 24, 2	2003-06-24
Immunological control of beta-amyloid levels in vivo App 20020136718 - Raso, Victor	2002-09-26
Immunological control of beta-amyloid levels in vivo App 20020102261 - Raso, Victor	2002-08-01
Anti-idiotype vaccines to elicit catalytic antibodies Grant 6,140,091 - Raso , et al. October 31, 2	2000-10-31
Method for delivering functional domains of diphtheria toxin to a cellular target Grant 5,830,478 - Raso , et al. November 3, 1	1998-11-03
Method for delivering a bioactive molecule to a cellular target Grant 5,603,931 - Raso February 18, 1	1997-02-18
Method for constructing a hybrid reagent for delivering a bioactive molecule to a cellular target Grant 5,599,908 - Raso February 4, 1	1997-02-04
Isolation of a high molecular weight aortic endothelial cell growth inhibitor Grant 4,770,877 - Jacobson * September 13, 1	1988-09-13
Cell proliferation inhibitor and method of preparation Grant 4,534,967 - Jacobson , et al. August 13, 1	1985-08-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.